New Nordic Healthbrands ABOMXSTO: NNH

NNH: Strong sales growth and margin improvement, but outlook clouded by tariff risks

· Issued by New Nordic Healthbrands AB

Net sales grew 10.4% year-over-year to 143.8 MSEK, with improved profitability and strong growth in North America and the UK. Management expects continued growth but highlights risks from new tariffs and volatile consumer behavior.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

New Nordic Healthbrands AB on 6ix

Earlier from New Nordic Healthbrands

Later from New Nordic Healthbrands

All New Nordic Healthbrands news releases